Bernard Prendergast

Showing 1-20 of 27 articles

A computed tomography study of coronary access and coronary obstruction after redo transcatheter aortic valve implantation

Buzzatti N, Montorfano M, Romano V, De Backer O, Søndergaard L, Rosseel L, Maurovich-Horvat P, Karady J, Merkely B, Prendergast B, De Bonis M, Colombo A, Latib A

December 18, 2020 | 10.4244/EIJ-D-20-00475

PCR Valves e-Course 2020: lifelong learning never stops. PCR London Valves goes virtual!

Tamburino C, Piazza N, Baumbach A, Windecker S, Maisano F, Prendergast B

November 20, 2020 | 10.4244/EIJV16I10A145

A novel supra-annular plane to predict TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane

Iannopollo G, Romano V, Buzzatti N, De Backer O, Søndergaard L, Merkely B, Prendergast B, Giannini F, Colombo A, Latib A, Granada J, Chieffo A, Montorfano M

June 25, 2020 | 10.4244/EIJ-D-19-00951

Interventions for valvular disease

Feasibility and safety of transcaval transcatheter aortic valve implantation: a multicentre European registry

Costa G, De Backer O, Pilgrim T, Kasel A, Redwood S, Aminian A, Lanz J, Michel J, Patterson T, Windecker S, Prendergast B, Greenbaum A, Søndergaard L

February 7, 2020 | 10.4244/EIJ-D-19-00797

2019 – A leap year for valvular heart disease

Tamburino C, Piazza N, Baumbach A, Windecker S, Maisano F, Prendergast B

November 15, 2019 | 10.4244/EIJV15I10A154

Residual challenges in TAVI: moving forward

Barbanti M, Webb J, Dvir D, Prendergast B

November 15, 2019 | 10.4244/EIJ-D-19-00788

Mitral valve regurgitation: a plea for transcatheter mitral valve replacement

Modine T, Prendergast B, Piazza N, Overtchouk P

September 20, 2019 | 10.4244/EIJV15I7A103

Interventions for valvular disease

The evolution of device technology in transcatheter aortic valve implantation

Bourantas C, Modolo R, Baumbach A, Søndergaard L, Prendergast B, Ozkor M, Kennon S, Mathur A, Mullen M, Serruys P

April 5, 2019 | 10.4244/EIJ-D-18-01048

PCI in TAVI patients: who, why and when?

Patterson T, Prendergast B, Redwood S

December 7, 2018 | 10.4244/EIJV14I11A209

Optimal structure of TAVI heart centres in 2018

Nerla R, Prendergast B, Castriota F

September 7, 2018 | 10.4244/EIJ-D-18-00656

Welcome to PCR London Valves 2018: 10th Anniversary Edition

Barbanti M, Prendergast B, Haude M, Piazza N, Windecker S, Baumbach A, Tamburino C

September 7, 2018 | 10.4244/EIJV14SABA1

PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?

Dawkins S, Modine T, Windecker S, Piazza N, Prendergast B

November 20, 2017 | 10.4244/EIJV13I10A178

Transcatheter aortic valve implantation – practice makes perfect

Dawkins S, Prendergast B

October 20, 2017 | 10.4244/EIJV13I8A132

Interventions for valvular disease

Welcome to PCR London Valves 2017

Tamburino C, Haude M, Windecker S, Piazza N, Prendergast B

September 24, 2017 | 10.4244/EIJV13SAAA1

Interventions for valvular disease

The big parade: emerging percutaneous mitral and tricuspid valve devices

Natarajan D, Joseph J, Denti P, Redwood S, Prendergast B

September 24, 2017 | 10.4244/EIJ-D-17-00571

Coronary interventions

A tool for predicting the outcome of reperfusion in ST-elevation myocardial infarction using age, thrombotic burden and index of microcirculatory resistance (ATI score)

De Maria G, Fahrni G, Alkhalil M, Cuculi F, Dawkins S, Wolfrum M, Choudhury R, Forfar J, Prendergast B, Yetgin T, van Geuns R, Tebaldi M, Channon KM, Kharbanda R, Rothwell P, Valgimigli M, Banning A

November 20, 2016 | 10.4244/EIJV12I10A202

Interventions for valvular disease

Durability of transcatheter heart valves – much ado about nothing

Prendergast B, Tamburino C, Piazza N, Haude M, Windecker S

September 18, 2016 | 10.4244/EIJV12I7A134

Interventions for valvular disease

Welcome to PCR London Valves 2016: back to the UK

Tamburino C, Windecker S, Piazza N, Haude M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA1

Interventions for valvular disease

Intrepid transcatheter mitral valve replacement system: technical and product description

Meredith I, Bapat V, Morriss J, McLean M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA21

Interventions for valvular disease

Percutaneous interventional options for the treatment of tricuspid regurgitation

Haude M, Prendergast B

September 18, 2016 | 10.4244/EIJV12SYA28

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...